- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04718129
Testing the Effect of the Youth Mindful Awareness Program on Negative Affect (YMAP)
August 17, 2023 updated by: Judith Garber, Vanderbilt University
Targeting Negative Affect Through Mindfulness Training in Youth at Risk for Internalizing Problems - R61
Randomized controlled trial comparing a coached, app-based mindfulness intervention versus a no-intervention control condition.
Primary outcome: adolescents' reports of affect as measured with ecological momentary assessment (EMA) at post-intervention.
Participants will include 120 youth ages 12-17 years old.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a randomized controlled trial testing a 9-session, coached, app-based mindfulness intervention on adolescents' reports of affect as measured with ecological momentary assessment (EMA).
Participants will include 120 youth ages 12- to 17-years-old randomized to either the Youth Mindful Awareness Program (YMAP) or to an assessment only control condition.
Participation is open to all genders and youth of all races and ethnicities.
Study Type
Interventional
Enrollment (Actual)
110
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Judy Garber, PhD
- Phone Number: 1-615-343-8714
- Email: judy.garber@vanderbilt.edu
Study Contact Backup
- Name: Jennifer Fuller, M.A.
- Phone Number: 1-615-343-8714
- Email: jennifer.fuller@vanderbilt.edu
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37203
- Judy Garber
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 17 years (Child)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- ages 12- to 17-years-old
- has access to a smartphone, tablet, or other mobile device on which they can access the mindfulness app and complete EMA reports. Youth without a device will be provided with one for their time in the study.
Exclusion Criteria:
- current DSM5 diagnosis of an anxiety or depressive disorder with significant clinical impairment
- current alcohol or substance use disorder; currently suicidal
- lifetime diagnosis of bipolar disorder, schizophrenia, autism, conduct disorder, or developmental delay
- reading level below 4th grade
- not English speaking at a level that would allow them to participate in the intervention and assessments.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mindfulness
Internet-based, coached Mindfulness Program.
Nine weekly coached sessions with practice exercises between sessions.
|
The Mindfulness Intervention is an internet-based program that involves a coach.
It is 9 weekly sessions and involves practicing the skills between sessions.
|
No Intervention: Control
Participants in this arm are randomly assigned to an assessment-only, no intervention control condition.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Negative Affect assessed with Ecological Momentary Assessment
Time Frame: Through study completion, an average of 12 weeks
|
The measure of momentary negative affect includes 7 items rated on a 4-point scale; average scores can range from 1.00 to 4.00.
Higher scores indicate more negative affect.
|
Through study completion, an average of 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Judy Garber, PhD, Vanderbilt University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 15, 2021
Primary Completion (Actual)
June 30, 2023
Study Completion (Actual)
July 5, 2023
Study Registration Dates
First Submitted
November 29, 2020
First Submitted That Met QC Criteria
January 15, 2021
First Posted (Actual)
January 22, 2021
Study Record Updates
Last Update Posted (Actual)
August 22, 2023
Last Update Submitted That Met QC Criteria
August 17, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 570035
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Results will be shared through Clinical Trials.gov, and by the study PIs at scientific conferences and publications in scientific journals.
IPD will be available upon request.
IPD Sharing Time Frame
Data will be available after study completion and publications of study results.
IPD Sharing Access Criteria
Access to study data will require a written request to the PIs.
The request should include a description of the research question(s), planned analyses, and data requested.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mindfulness
-
Chinese University of Hong KongCompleted
-
Medical Research Council Cognition and Brain Sciences...University of CambridgeActive, not recruiting
-
University of LuxembourgLuxembourg National Research Fund (FNR)CompletedHealthy Aging | MindfulnessLuxembourg
-
Massachusetts General HospitalCompletedMindfulness | Orthopaedic InjuryUnited States
-
Northwestern UniversityUniversity of Pittsburgh; National Institutes of Health (NIH); National Center...CompletedCreating and Optimizing Mindfulness Measures to Enhance and Normalize Clinical Evaluation (COMMENCE)MindfulnessUnited States
-
Colorado State UniversityCompleted
-
Bahcesehir Cyprus UniversityCompleted
Clinical Trials on Youth Mindful Awareness Program (YMAP)
-
National University, SingaporeCompleted
-
University of California, Los AngelesCompletedHealth Behavior Modification Using MindfulnessUnited States
-
Drexel UniversityActive, not recruitingObesity | Weight LossUnited States
-
Seattle Children's HospitalUniversity of Washington; National Center for Complementary and Integrative...UnknownSleep Initiation and Maintenance DisordersUnited States
-
University of California, Los AngelesCompleted
-
Children's Hospital Medical Center, CincinnatiCompleted
-
University of California, Los AngelesCompletedStress | Burnout, ProfessionalUnited States
-
Jonsson Comprehensive Cancer CenterSusan G. Komen Breast Cancer FoundationCompletedYounger Breast Cancer SurvivorsUnited States
-
University of California, Los AngelesRecruitingDysautonomia | Long COVIDUnited States
-
University of WashingtonNational Institute on Drug Abuse (NIDA)CompletedSubstance Use DisorderUnited States